Vav-2 controls NFAT-dependent transcription in B- but not T-lymphocytes

被引:66
作者
Doody, GM
Billadeau, DD
Clayton, E
Hutchings, A
Berland, R
McAdam, S
Leibson, PJ
Turner, M [1 ]
机构
[1] Babraham Inst, Mol Immunol Programme, Lymphocyte Signaling & Dev Lab, Cambridge CB2 4AT, England
[2] Mayo Clin, May Grad & Med Sch, Dept Immunol, Rochester, MN 55905 USA
[3] Tufts Univ, Sch Med, Dept Pathol, Boston, MA 02111 USA
关键词
CD19; lymphocyte; RhoG; signaling; Vav;
D O I
10.1093/emboj/19.22.6173
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We show here that Vav-2 is tyrosine phosphorylated following antigen receptor engagement in both B- and T-cells, but potentiates nuclear factor of activated T cells (NFAT)-dependent transcription only in B cells, Vav-2 function requires the N-terminus, as well as functional Dbl homology and SH2 domains. Moreover, the enhancement of NFAT-dependent transcription by Vav-2 can be inhibited by a number of dominant-negative GTPases, The ability of Vav-2 to potentiate NFAT-dependent transcription correlates with its ability to promote a sustained calcium flux. Thus, Vav-2 augments the calcium signal in B cells but not T cells, and a truncated form of Vav-2 can neither activate NFAT nor augment calcium signaling. The CD19 co-receptor physically interacts with Vav-2 and synergistically enhances Vav-2 phosphorylation induced by the B-cell receptor (BCR), In addition, we found that Vav-2 augments CD19-stimulated NFAT-dependent transcription, as well as transcription from the CD5 enhancer. These data suggest a role for Vav-2 in transducing BCR signals to the transcription factor NFAT and implicate Vav-2 in the integration of BCR and CD19 signaling.
引用
收藏
页码:6173 / 6184
页数:12
相关论文
共 59 条
  • [31] THE RHO-FAMILY GTPASES RHOA, RAC1, AND CDC42HS REGULATE TRANSCRIPTIONAL ACTIVATION BY SRF
    HILL, CS
    WYNNE, J
    TREISMAN, R
    [J]. CELL, 1995, 81 (07) : 1159 - 1170
  • [32] SIGNAL-TRANSDUCTION IN T-LYMPHOCYTES USING A CONDITIONAL ALLELE OF SOS
    HOLSINGER, LJ
    SPENCER, DM
    AUSTIN, DJ
    SCHREIBER, SL
    CRABTREE, GR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (21) : 9810 - 9814
  • [33] Defects in actin-cap formation in Vav-deficient mice implicate an actin requirement for lymphocyte signal transduction
    Holsinger, LJ
    Graef, IA
    Swat, W
    Chi, T
    Bautista, DM
    Davidson, L
    Lewis, RS
    Alt, FW
    Crabtree, GR
    [J]. CURRENT BIOLOGY, 1998, 8 (10) : 563 - 572
  • [34] LOSS OF THE AMINO-TERMINAL HELIX-LOOP-HELIX DOMAIN OF THE VAV PROTOONCOGENE ACTIVATES ITS TRANSFORMING POTENTIAL
    KATZAV, S
    CLEVELAND, JL
    HESLOP, HE
    PULIDO, D
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1991, 11 (04) : 1912 - 1920
  • [35] A guanine nucleotide exchange factor-independent function of Vav1 in transcriptional activation
    Kuhne, MR
    Ku, G
    Weiss, A
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (03) : 2185 - 2190
  • [36] Tyrosine phosphorylation mediates both activation and downmodulation of the biological activity of Vav
    López-Lago, M
    Lee, K
    Cruz, C
    Movilla, N
    Bustelo, XR
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (05) : 1678 - 1691
  • [37] TYROSINE PHOSPHORYLATION OF VAV PROTOONCOGENE PRODUCT CONTAINING SH2 DOMAIN AND TRANSCRIPTION FACTOR MOTIFS
    MARGOLIS, B
    HU, P
    KATZAV, S
    LI, W
    OLIVER, JM
    ULLRICH, A
    WEISS, A
    SCHLESSINGER, J
    [J]. NATURE, 1992, 356 (6364) : 71 - 74
  • [38] Meyer KB, 1998, EUR J IMMUNOL, V28, P1467, DOI 10.1002/(SICI)1521-4141(199805)28:05<1467::AID-IMMU1467>3.0.CO
  • [39] 2-9
  • [40] CD19 as a membrane-anchored adaptor protein of B lymphocytes: Costimulation of lipid and protein kinases by recruitment of Vav
    O'Rourke, LM
    Tooze, R
    Turner, M
    Sandoval, DM
    Carter, RH
    Tybulewicz, VLJ
    Fearon, DT
    [J]. IMMUNITY, 1998, 8 (05) : 635 - 645